Healthcare provider profile · identity verified

Anjali Gupta, MD

Internal Medicine · LIVONIA, MI · NPI 1467653261

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	461	68
Levothyroxine Sodium	Levothyroxine Sodium	375	47
Furosemide	Furosemide	322	53
Amlodipine Besylate	Amlodipine Besylate	253	43
Metoprolol Tartrate	Metoprolol Tartrate	243	43
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	240	40
Eliquis	Apixaban	229	28
Gabapentin	Gabapentin	219	39
Hydralazine Hcl	Hydralazine Hcl	176	27
Losartan Potassium	Losartan Potassium	169	23
Lisinopril	Lisinopril	160	20
Pantoprazole Sodium	Pantoprazole Sodium	151	27
Potassium Chloride	Potassium Chloride	136	28
Tramadol Hcl	Tramadol Hcl	134	27
Trazodone Hcl	Trazodone Hcl	132	25
Omeprazole	Omeprazole	129	27
Sertraline Hcl	Sertraline Hcl	113	21
Alprazolam	Alprazolam	108	27
Ondansetron Hcl	Ondansetron Hcl	97	32
Metoprolol Succinate	Metoprolol Succinate	96	19
Donepezil Hcl	Donepezil Hcl	93	15
Tamsulosin Hcl	Tamsulosin Hcl	92	16
Clopidogrel	Clopidogrel Bisulfate	89	15
Simvastatin	Simvastatin	81	suppressed
Carvedilol	Carvedilol	77	16
Quetiapine Fumarate	Quetiapine Fumarate	75	14
Memantine Hcl	Memantine Hcl	73	suppressed
Lactulose	Lactulose	71	20
Metformin Hcl	Metformin Hcl	69	13
Levetiracetam	Levetiracetam	66	11
Lorazepam	Lorazepam	66	18
Xarelto	Rivaroxaban	65	suppressed
Allopurinol	Allopurinol	60	12
Nifedipine Er	Nifedipine	60	suppressed
Pregabalin	Pregabalin	58	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	16
Mirtazapine	Mirtazapine	56	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	suppressed
Famotidine	Famotidine	49	11
Hydrochlorothiazide	Hydrochlorothiazide	49	suppressed
Divalproex Sodium	Divalproex Sodium	48	suppressed
Midodrine Hcl	Midodrine Hcl	47	13
Baclofen	Baclofen	46	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	46	11
Latanoprost	Latanoprost	44	12
Oxycodone Hcl	Oxycodone Hcl	43	suppressed
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Bumetanide	Bumetanide	38	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	36	19
Cephalexin	Cephalexin	35	22
Glipizide	Glipizide	35	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	suppressed
Olanzapine	Olanzapine	32	suppressed
Primidone	Primidone	31	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Ammonium Lactate	Ammonium Lactate	28	12
Duloxetine Hcl	Duloxetine Hcl	28	suppressed
Ibuprofen	Ibuprofen	28	12
Lovastatin	Lovastatin	28	suppressed
Montelukast Sodium	Montelukast Sodium	28	suppressed
Enulose	Lactulose	25	suppressed
Finasteride	Finasteride	25	suppressed
Prednisone	Prednisone	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	17
Carbidopa-Levodopa	Carbidopa/Levodopa	24	suppressed
Atenolol	Atenolol	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	17
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Torsemide	Torsemide	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Phenobarbital	Phenobarbital	20	suppressed
Ranolazine Er	Ranolazine	20	suppressed
Risperidone	Risperidone	20	suppressed
Single Use Swab	Alcohol Antiseptic Pads	20	suppressed
Santyl	Collagenase Clostridium Hist.	19	suppressed
Albuterol Sulfate	Albuterol Sulfate	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Nystatin	Nystatin	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Digoxin	Digoxin	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Risperidone Er	Risperidone Microspheres	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Haloperidol	Haloperidol	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Insulin Aspart Flexpen	Insulin Aspart	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Belsomra	Suvorexant	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	11
Tolterodine Tartrate	Tolterodine Tartrate	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Fluticasone Propionate	Fluticasone Propionate	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Fluconazole	Fluconazole	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error